Clinical Trials › NCT04749667
Active, Not RecruitingPhase 1
Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis
Sponsored by Haukeland University Hospital
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 18
Target enrollment
Aug 2021
Start date
Mar 2027
Expected completion
Interventions / Treatments
MSCsSaline
Conditions studied
Multiple SclerosisProgressive Multiple Sclerosis
Trial locations
U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.
More Phase 1 trials
Browse all Phase 1 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.